Home » Topics » Regulatory » Patents

Patents
RSS

Neuron23 divulges LRRK2/NUAK1/TYK2 inhibitors

June 7, 2022

New cytokine inhibitors patented by Peptinov SAS, Conservatoire National des Arts et Metiers

June 7, 2022

New HSD17B13 inhibitors discovered at Inipharm

June 7, 2022

Genentech describes von Hippel-Lindau disease tumor suppressor inhibitors

June 7, 2022

BioWorld MedTech Patent Highlights: Week 21

From Current Patent Gazette

June 3, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

RIKEN presents new immunostimulants

June 3, 2022

New lysophosphatidic acid receptor 1 antagonists patented by Humanwell Healthcare

June 3, 2022

Guangzhou Henovcom Bioscience discovers autotaxin inhibitors

June 3, 2022

Hongyun Biotech presents new MAP4K1 inhibitors

June 3, 2022

New Rho kinase 2 inhibitors identified at Medshine Discovery

June 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...